{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:24:16Z","timestamp":1792653856729,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jconrel.2022.04.036","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T17:51:18Z","timestamp":1651341078000},"page":"380-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Oil-in-ionic liquid nanoemulsion-based intranasal delivery system for influenza split-virus vaccine"],"prefix":"10.1016","volume":"346","author":[{"given":"Xuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.04.036_bb0005","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.addr.2020.12.006","article-title":"Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection","volume":"169","author":"Batty","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121180","article-title":"Intranasal vaccine: factors to consider in research and development","volume":"609","author":"Xu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/1348-0421.12775","article-title":"Human immune responses elicited by an intranasal inactivated H5 influenza vaccine","volume":"64","author":"Ainai","year":"2020","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7774\/cevr.2012.1.1.50","article-title":"Mucosal vaccine adjuvants update","volume":"1","author":"Rhee","year":"2012","journal-title":"Clin.Exp. Vacc. Res."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0040","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4161\/hv.25458","article-title":"Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults","volume":"9","author":"Ainai","year":"2013","journal-title":"Hum. Vacc. Immunother."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0045","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1473-3099(20)30274-7","article-title":"Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study","volume":"20","author":"Jahnmatz","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0050","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1172\/JCI135020","article-title":"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans","volume":"130","author":"Lin","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/1061186X.2010.523790","article-title":"Nasal vaccine innovation","volume":"18","author":"Jabbal-Gill","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.addr.2009.11.012","article-title":"Nanotechnology solutions for mucosal immunization","volume":"62","author":"Chadwick","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0070","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2007.11.045","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination","volume":"26","author":"Vijaysri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1208\/s12249-013-0058-7","article-title":"Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine","volume":"15","author":"Sawaengsak","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0080","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biomaterials.2011.11.068","article-title":"Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization","volume":"33","author":"Wu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.addr.2009.11.009","article-title":"Chitosan-based delivery systems for protein therapeutics and antigens","volume":"62","author":"Amidi","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0090","doi-asserted-by":"crossref","first-page":"2000771","DOI":"10.1002\/advs.202000771","article-title":"Mucosal vaccination for influenza protection enhanced by catalytic immune-adjuvant","volume":"7","author":"Qin","year":"2020","journal-title":"Adv.Sci."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijbiomac.2017.10.101","article-title":"Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases","volume":"110","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2011.10.094","article-title":"Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens","volume":"30","author":"Stanberry","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002954","article-title":"Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine","volume":"3","author":"Makidon","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/10611860801900082","article-title":"Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice","volume":"16","author":"Shahiwala","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0115","article-title":"Rational application of nanoadjuvant for mucosal vaccine delivery system","volume":"481","author":"Dewangan","year":"2020","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9090998","article-title":"Safety and efficacy of spray intranasal live attenuated influenza vaccine: systematic review and meta-analysis","volume":"9","author":"Perego","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0125","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01598-21","article-title":"Oral bacteria combined with an intranasal vaccine protect from influenza a virus and SARS-CoV-2 infection","volume":"12","author":"Nagai","year":"2021","journal-title":"Mbio"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0135","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0140","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/IAI.74.5.2856-2866.2006","article-title":"Mucosal adjuvant properties of the Shigella invasin complex","volume":"74","author":"Kaminski","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0145","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1039\/C6MD00358C","article-title":"Ionic liquids as a potential tool for drug delivery systems","volume":"7","author":"Adawiyah","year":"2016","journal-title":"Medchemcomm"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/528188a","article-title":"Develop ionic liquid drugs","volume":"528","author":"Shamshina","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cjche.2020.11.015","article-title":"The potential of ionic liquids in biopharmaceutical engineering","volume":"30","author":"Lin","year":"2021","journal-title":"Chin. J. Chem. Eng."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0160","doi-asserted-by":"crossref","first-page":"201722338","DOI":"10.1073\/pnas.1722338115","article-title":"Ionic liquids for oral insulin delivery","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0165","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1039\/C3CC48650H","article-title":"Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility","volume":"50","author":"Williams","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0170","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1252\/jcej.13we009","article-title":"Ionic liquid-in-oil microemulsions as potential carriers for the transdermal delivery of methotrexate","volume":"46","author":"Yoshiura","year":"2013","journal-title":"J. Chem. Eng. Jpn"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0175","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1039\/C5MD00378D","article-title":"Ionic liquid-mediated transcutaneous protein delivery with solid-in-oil nanodispersions","volume":"6","author":"Araki","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2020.04.038","article-title":"Topical delivery of siRNA into skin using ionic liquids","volume":"323","author":"Dharamdasani","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0185","doi-asserted-by":"crossref","first-page":"1601411","DOI":"10.1002\/adhm.201601411","article-title":"Transdermal protein delivery using choline and geranate (CAGE) deep eutectic solvent","volume":"6","author":"Banerjee","year":"2017","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fphar.2020.00243","article-title":"Non-invasive transdermal delivery of human insulin using ionic liquids: in vitro studies","volume":"11","author":"Jorge","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0195","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1021\/acs.molpharmaceut.0c00598","article-title":"Biocompatible ionic liquid enhances transdermal antigen peptide delivery and preventive vaccination effect","volume":"17","author":"Tahara","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0200","doi-asserted-by":"crossref","first-page":"2002990","DOI":"10.1002\/adma.202002990","article-title":"Ionic-Liquid-Based Safe Adjuvants","volume":"32","author":"Ukidve","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0205","first-page":"3","article-title":"Nutritional aspect of tryptophan metabolism","volume":"6","author":"Fukuwatari","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0210","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.molliq.2018.12.085","article-title":"What is the taste of vitamin-based ionic liquids?","volume":"276","author":"Vranes","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.molliq.2017.10.015","article-title":"Physicochemical features and toxicity of some vitamin based ionic liquids","volume":"247","author":"Vranes","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0225","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1586\/14760584.7.9.1435","article-title":"Innate sensors of influenza virus: clues to developing better intranasal vaccines","volume":"7","author":"Ichinohe","year":"2008","journal-title":"Expert Rev. Vacc."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines","volume":"58","author":"Tamura","year":"2005","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev-immunol-032414-112315","article-title":"Exploiting mucosal immunity for antiviral vaccines","volume":"34","author":"Iwasaki","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0240","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"Th1-cell and Th2-cell - different patterns of lymphokine secretion lead to different functional-properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/btm2.10083","article-title":"Ionic liquids for addressing unmet needs in healthcare","volume":"3","author":"Agatemor","year":"2018","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/pharmaceutics11020096","article-title":"Ionic liquids as potential and synergistic permeation enhancers for transdermal drug delivery","volume":"11","author":"Sidat","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0255","first-page":"2002912","article-title":"Ionic liquids and deep eutectic solvents for enhanced delivery of antibodies in the gastrointestinal tract","author":"Angsantikul","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0260","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0265","doi-asserted-by":"crossref","first-page":"12090","DOI":"10.1128\/JVI.01469-13","article-title":"TLR3-and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate","volume":"87","author":"Xia","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0270","article-title":"\"World in motion\" - emulsion adjuvants rising to meet the pandemic challenges","volume":"6","author":"O'Hagan","year":"2021","journal-title":"Npj Vacc."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0275","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2022.04.036_bb0280","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - An innately attractive adjuvant formulation","volume":"30","author":"O\u2019Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.04.036_bb0285","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1039\/b918726j","article-title":"Cyto-toxicity and biocompatibility of a family of choline phosphate ionic liquids designed for pharmaceutical applications","volume":"12","author":"Weaver","year":"2010","journal-title":"Green Chem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922002322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922002322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:27:18Z","timestamp":1759163238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922002322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":57,"alternative-id":["S0168365922002322"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.036","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oil-in-ionic liquid nanoemulsion-based intranasal delivery system for influenza split-virus vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}